Iovance Biotherapeut...
NasdaqGM:IOVA
$ 3,70
$-0,30 (-7,50%)
3,70 $
$-0,30 (-7,50%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,09
Earnings Per Share
$0,64
Revenue Per Share
34,28%
Gross Margin %
$1,65 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-1,09
Revenue Per Share
$0,64
Gross Margin %
34,28%
Market Cap
$1,65 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share $-1,09 $-1,28 $-1,89 $-2,49 $-2,23 $-1,88 $-1,59 $-1,27 $-1,23 $-0,62 $-0,62 $-0,48 $-3,47
Earnings Earnings $-449,04M $-419,69M $-527,90M $-558,36M $-350,49M $-276,32M $-201,14M $-156,74M $-110,02M $-38,63M $-30,11M $-21,16M $-76,55M
RPS Revenue Per Share $0,00 $0,64 $0,50 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $0,00M $263,50M $164,07M $1,19M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-328,72M $-352,98M $-361,82M $-292,76M $-227,94M $-205,13M $-158,89M $0,00M $-78,71M $-32,67M $-18,38M $-8,63M $0,00M
FCF Free Cash Flow $0,00M $-292,00M $-364,05M $-384,11M $-313,18M $-265,52M $-251,93M $-165,81M $-102,45M $-91,72M $-34,19M $-19,52M $-10,23M $0,00M
OM Operating Margin 0,00% -151,12% -240,92% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 34,28% 24,43% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-0,94 $-1,26 $-1,63 $-1,97 $-1,73 $-1,82 $-1,33 $-1,05 $-1,22 $-0,62 $-0,44 $-0,41 $-0,38
LT Debt Long-Term Debt N/A N/A $1,00M $1,00M $1,00M $1,00M N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 411,96M 411,96M 327,88M 279,31M 224,24M 157,17M 146,98M 126,5M 123,42M 89,45M 62,31M 48,57M 44,08M 22,06M
×